BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 27564267)

  • 1. Flow cytometry-based TCR-ligand Koff -rate assay for fast avidity screening of even very small antigen-specific T cell populations ex vivo.
    Nauerth M; Stemberger C; Mohr F; Weißbrich B; Schiemann M; Germeroth L; Busch DH
    Cytometry A; 2016 Sep; 89(9):816-25. PubMed ID: 27564267
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mixed functional characteristics correlating with TCR-ligand koff -rate of MHC-tetramer reactive T cells within the naive T-cell repertoire.
    Hombrink P; Raz Y; Kester MG; de Boer R; Weißbrich B; von dem Borne PA; Busch DH; Schumacher TN; Falkenburg JH; Heemskerk MH
    Eur J Immunol; 2013 Nov; 43(11):3038-50. PubMed ID: 23893393
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TCR-ligand koff rate correlates with the protective capacity of antigen-specific CD8+ T cells for adoptive transfer.
    Nauerth M; Weißbrich B; Knall R; Franz T; Dössinger G; Bet J; Paszkiewicz PJ; Pfeifer L; Bunse M; Uckert W; Holtappels R; Gillert-Marien D; Neuenhahn M; Krackhardt A; Reddehase MJ; Riddell SR; Busch DH
    Sci Transl Med; 2013 Jul; 5(192):192ra87. PubMed ID: 23825303
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative TCR:pMHC Dissociation Rate Assessment by NTAmers Reveals Antimelanoma T Cell Repertoires Enriched for High Functional Competence.
    Gannon PO; Wieckowski S; Baumgaertner P; Hebeisen M; Allard M; Speiser DE; Rufer N
    J Immunol; 2015 Jul; 195(1):356-66. PubMed ID: 26002978
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of Rare High-Avidity, Tumor-Reactive CD8+ T Cells by Monomeric TCR-Ligand Off-Rates Measurements on Living Cells.
    Hebeisen M; Schmidt J; Guillaume P; Baumgaertner P; Speiser DE; Luescher I; Rufer N
    Cancer Res; 2015 May; 75(10):1983-91. PubMed ID: 25808864
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An Essential Role of the Avidity of T-Cell Receptor in Differentiation of Self-Antigen-reactive CD8+ T Cells.
    Kondo K; Fujiki F; Nakajima H; Yatsukawa E; Morimoto S; Tatsumi N; Nishida S; Nakata J; Oka Y; Tsuboi A; Hosen N; Oji Y; Sugiyama H
    J Immunother; 2016 Apr; 39(3):127-39. PubMed ID: 26938946
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A correlation between function and selected measures of T cell avidity in influenza virus-specific CD8+ T cell responses.
    La Gruta NL; Doherty PC; Turner SJ
    Eur J Immunol; 2006 Nov; 36(11):2951-9. PubMed ID: 17072910
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Highly protective in vivo function of cytomegalovirus IE1 epitope-specific memory CD8 T cells purified by T-cell receptor-based cell sorting.
    Pahl-Seibert MF; Juelch M; Podlech J; Thomas D; Deegen P; Reddehase MJ; Holtappels R
    J Virol; 2005 May; 79(9):5400-13. PubMed ID: 15827154
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rapid assessment of recognition efficiency and functional capacity of antigen-specific T-cell responses.
    Kohrt HE; Shu CT; Stuge TB; Holmes SP; Weber J; Lee PP
    J Immunother; 2005; 28(4):297-305. PubMed ID: 16000947
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Flow-microfluorometric monitoring of oligoclonal CD8+ T cell responses to an immunodominant Moloney leukemia virus-encoded epitope in vivo.
    Brawand P; Biasi G; Horvath C; Cerottini JC; MacDonald HR
    J Immunol; 1998 Feb; 160(4):1659-65. PubMed ID: 9469422
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SLAP deficiency increases TCR avidity leading to altered repertoire and negative selection of cognate antigen-specific CD8+ T cells.
    Friend SF; Peterson LK; Kedl RM; Dragone LL
    Immunol Res; 2013 Mar; 55(1-3):116-24. PubMed ID: 22956467
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Avidity characterization of genetically engineered T-cells with novel and established approaches.
    Hillerdal V; Boura VF; Björkelund H; Andersson K; Essand M
    BMC Immunol; 2016 Jul; 17(1):23. PubMed ID: 27411667
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relevance of peptide avidity to the T cell receptor for cytomegalovirus-specific ex vivo CD8 T cell cytotoxicity.
    Villacres MC; Lacey SF; Auge C; Longmate J; Leedom JM; Diamond DJ
    J Infect Dis; 2003 Sep; 188(6):908-18. PubMed ID: 12964124
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fluorescent target array T helper assay: a multiplex flow cytometry assay to measure antigen-specific CD4+ T cell-mediated B cell help in vivo.
    Quah BJ; Wijesundara DK; Ranasinghe C; Parish CR
    J Immunol Methods; 2013 Jan; 387(1-2):181-90. PubMed ID: 23123200
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Isolation of high avidity melanoma-reactive CTL from heterogeneous populations using peptide-MHC tetramers.
    Yee C; Savage PA; Lee PP; Davis MM; Greenberg PD
    J Immunol; 1999 Feb; 162(4):2227-34. PubMed ID: 9973498
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Loss of CTL function among high-avidity tumor-specific CD8+ T cells following tumor infiltration.
    Janicki CN; Jenkinson SR; Williams NA; Morgan DJ
    Cancer Res; 2008 Apr; 68(8):2993-3000. PubMed ID: 18413769
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The efficiency of antigen recognition by CD8+ CTL clones is determined by the frequency of serial TCR engagement.
    Hudrisier D; Kessler B; Valitutti S; Horvath C; Cerottini JC; Luescher IF
    J Immunol; 1998 Jul; 161(2):553-62. PubMed ID: 9670927
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tracing and characterization of the low-avidity self-specific T cell repertoire.
    de Visser KE; Cordaro TA; Kioussis D; Haanen JB; Schumacher TN; Kruisbeek AM
    Eur J Immunol; 2000 May; 30(5):1458-68. PubMed ID: 10820394
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential kinetics of antigen dependency of CD4+ and CD8+ T cells.
    Rabenstein H; Behrendt AC; Ellwart JW; Naumann R; Horsch M; Beckers J; Obst R
    J Immunol; 2014 Apr; 192(8):3507-17. PubMed ID: 24639353
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Global k
    Lückemeier P; Molter KL; Jarosch S; Huppertz P; Purcarea A; Effenberger MJP; Nauerth M; D'Ippolito E; Schober K; Busch DH
    Eur J Immunol; 2022 Apr; 52(4):582-596. PubMed ID: 35099805
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.